Akari Therapeutics Plc (AKTX)
0.216
+0.01
(+4.35%)
USD |
NASDAQ |
Mar 17, 16:00
0.1956
-0.02
(-9.44%)
Pre-Market: 08:07
Akari Therapeutics Shareholders Equity (Quarterly) : 22.69M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| DBV Technologies SA | 52.85M |
| Cellectis SA | 100.48M |
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | 46.60M |
| Evaxion AS | 16.60M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 45.38M |
| Total Liabilities (Quarterly) | 22.69M |
| Debt to Equity Ratio | 0.0933 |
| Current Ratio | 0.1892 |
| Net Debt Paydown Yield | -1.29% |